Bernard Bihari, MD: low-dose naltrexone for normalizing immune system function
Bihari, B.; Bihari, B.
Alternative Therapies in Health and Medicine 19(2): 56-65
2013
ISSN/ISBN: 1078-6791 PMID: 23594453 Document Number: 667576
Document emailed within 1 workday
Related Documents
Dayton, K.D.; Lancaster, L.E. 1995: The immune system in patients with renal failure. Part 1: Review of immune function Anna Journal 22(6): 523-529Malspeis, L.; Bathala, M.S.; Ludden, T.M.; Bhat, H.B.; Frank, S.G.; Sokoloski, T.D.; Morrison, B.E.; Reuning, R.H. 1975: Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol Research Communications in Chemical Pathology and Pharmacology 12(1): 43-65
Jaros, J.; Lio, P. 2019: Low Dose Naltrexone in Dermatology Journal of Drugs in Dermatology: Jdd 18(3): 235-238
Manudhane, A.P.; Schrom, K.P.; Ezaldein, H.H.; Armile, J.A. 2019: Low-dose naltrexone: a unique treatment for amyopathic dermatomyositis Dermatology Online Journal 25(6)
Tortelly, V.D.; De Mattos, T.; Fernandes, L.S.d.A.; Nunes, B.E.M.; Melo, D.F. 2019: Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias? Dermatology Online Journal 25(8)
Muller, G.; Grieshaber, R.; Talley, J.Floyd.; Riepl, M.; Fellows, D. 2018: Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report International Journal of Pharmaceutical Compounding 22(4): 270-278
Turk, J.L. 1973: The immune system--morphology and function Ethiopian Medical Journal 11(2): 168-170
Demel, U.; Domej, W.; Tilz, G.P. 2000: Function and repertoire of the immune system in body's defense Wiener Medizinische Wochenschrift 150(8-9): 175-177
Tong, J.; Qin, L.; Geng, M. 1999: Dose-related effect of irradiation on circadian rhythm of cellular messengers in neural and immune system of mouse Chinese Medical Journal 112(2): 146-148
Bukovsky, A.; Presl, J. 1978: Role of the immune system in regulation of ovarian function-hypothesis Czechoslovak Medicine 1(4): 229-237
Fein, A.; Torchinsky, A.; Toder, V. 1998: Function of maternal immune-system and the embryonic sensitivity to teratogens Harefuah 134(3): 198-200
Rodriguez de Romo, A.C.; Borgstein, J.; Bernard, C. 1999: Claude Bernard and pancreatic function revisited after 150 years Vesalius: acta internationales historiae medicinae 5(1): 18-24
Braun, M. 1978: Suppressor lymphocytes: a new function of the immune system or a corrected and improved edition of the same history? Medicina 38(4): 467-469
Misra, A.L.; Bloch, R.; Vardy, J.; Mulé, S.J.; Verebely, K. 1976: Disposition of (15,16-3H)naltrexone in the central nervous system of the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 4(3): 276-280
Sustrová, M.; Saríková, V. 1997: Down's syndrome--effect of increased gene expression in chromosome 21 on the function of the immune and nervous system Bratislavske Lekarske Listy 98(4): 221-228
Grinevich, I.A.; Labunets, I.F. 1987: Hormonal function of the thymus in malignant melanoma of the skin; the interrelation with immune system disorders Voprosy Onkologii 33(6): 46-52
Mitchenko, I.K.; Bordonos, V.G.; Degtiarenko, O.M.; Kuiun, L.A.; Afonina, G.B. 1987: Circulating immune complexes and function of the T- and B-links of the immunity system of viral hepatitis B patients Vrachebnoe Delo 8: 119-120
Schned, E.S.; Inman, R.D.; Parris, T.M.; Kimberly, R.P.; Redecha, P.B.; Christian, C.L. 1983: Serial circulating immune complexes and mononuclear phagocyte system function in infective endocarditis Journal of Laboratory and Clinical Medicine 102(6): 947-959
Lahnborg, G.; Berghem, L.; Lagergren, H.; Schildt, B. 1976: Effect of low-dose heparin on the phagocytic and catabolic function in the reticulo-endothelial system in man during surgery Annales Chirurgiae et Gynaecologiae 65(6): 376-381
Scheid, C.; Pettengell, R.; Ghielmini, M.; Radford, J.A.; Morgenstern, G.R.; Stern, P.L.; Crowther, D. 1995: Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma Bone Marrow Transplantation 15(6): 901-906